In the present study, we investigate, in a model of Ang II-dependent hypertension, whether the beneficial effects of SGTL2 inhibitors on myocardial fibrosis and hypertrophy are mediated by the local modulation of the sympathetic nervous system and inflammation. This evidence concerns the gene AGT and Myocardial fibrosis.